AP2858A - Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor - Google Patents

Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor

Info

Publication number
AP2858A
AP2858A AP2011005715A AP2011005715A AP2858A AP 2858 A AP2858 A AP 2858A AP 2011005715 A AP2011005715 A AP 2011005715A AP 2011005715 A AP2011005715 A AP 2011005715A AP 2858 A AP2858 A AP 2858A
Authority
AP
ARIPO
Prior art keywords
diarylpyrimidine
synthesis
reverse transcriptase
nucleoside reverse
transcriptase inhibitor
Prior art date
Application number
AP2011005715A
Other languages
English (en)
Other versions
AP2011005715A0 (en
Inventor
Mukund Keshav Gurjar
Golakchandra Sudarshan Maikap
Shashikant Gangaram Joshi
Original Assignee
Emcure Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emcure Pharmaceuticals Ltd filed Critical Emcure Pharmaceuticals Ltd
Publication of AP2011005715A0 publication Critical patent/AP2011005715A0/xx
Application granted granted Critical
Publication of AP2858A publication Critical patent/AP2858A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AP2011005715A 2009-06-22 2010-06-18 Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor AP2858A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1479MU2009 2009-06-22
PCT/IN2010/000422 WO2010150279A2 (en) 2009-06-22 2010-06-18 Process for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor

Publications (2)

Publication Number Publication Date
AP2011005715A0 AP2011005715A0 (en) 2011-06-30
AP2858A true AP2858A (en) 2014-02-28

Family

ID=43386984

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005715A AP2858A (en) 2009-06-22 2010-06-18 Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor

Country Status (12)

Country Link
US (1) US20110196156A1 (xx)
EP (1) EP2342186B1 (xx)
JP (1) JP5406934B2 (xx)
AP (1) AP2858A (xx)
BR (1) BRPI1004934A2 (xx)
CO (1) CO6430461A2 (xx)
ES (1) ES2527103T3 (xx)
IL (1) IL214862A (xx)
RU (1) RU2556986C2 (xx)
UA (1) UA106972C2 (xx)
WO (1) WO2010150279A2 (xx)
ZA (1) ZA201108690B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017079A1 (en) 2009-07-27 2011-02-10 Teva Pharmaceutical Industries Ltd. Process for the preparation and purification of etravirine and intermediates thereof
GR1007010B (el) 2009-10-08 2010-10-07 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Ινσουλινοειδη πεπτιδια
PL2702045T3 (pl) 2011-04-26 2018-04-30 Mylan Laboratories Ltd. Nowy sposób sporządzania Etrawiryny
WO2012170647A1 (en) * 2011-06-09 2012-12-13 Assia Chemical Industriew Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
WO2013059572A1 (en) 2011-10-19 2013-04-25 Assia Chemical Industries Ltd. Process for the preparation of etravirine and intermediates in the synthesis thereof
WO2013159286A1 (zh) * 2012-04-24 2013-10-31 上海迪赛诺药业有限公司 依曲韦林及其中间体的制备方法
CN103373965B (zh) * 2012-04-24 2016-04-27 上海迪赛诺药业有限公司 依曲韦林及其中间体的制备方法
CN102675220B (zh) * 2012-05-28 2014-03-19 南京药石药物研发有限公司 一种制备依曲韦林的方法及其中间体
CN104447573B (zh) * 2014-11-27 2016-11-09 山东大学 一种依曲韦林的制备方法
RU2728555C1 (ru) * 2019-12-24 2020-07-30 Общество с ограниченной ответственностью "Балтфарма" Способ получения этравирина
CN111675661B (zh) * 2020-06-28 2021-08-24 山东大学 一种含有反式双键的二芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287270B6 (sk) 1998-11-10 2010-05-07 Janssen Pharmaceutica N. V. Derivát pyrimidínu
NZ517025A (en) * 1999-09-24 2003-07-25 Janssen Pharmaceutica Nv Antiviral compositions
RU2403244C2 (ru) * 2004-09-30 2010-11-10 Тиботек Фармасьютикалз Лтд. Вич-ингибирующие 5-карбо- или гетероциклические замещенные пиримидины
BRPI0607214B8 (pt) * 2005-01-27 2021-05-25 Janssen R & D Ireland derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação
EP1853567B1 (en) * 2005-02-18 2014-12-31 Janssen R&D Ireland Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives
JP5118978B2 (ja) * 2005-03-04 2013-01-16 テイボテク・フアーマシユーチカルズ Hiv阻害2−(4−シアノフェニル)−6−ヒドロキシルアミノピリミジン
UA95955C2 (ru) * 2006-07-24 2011-09-26 Кореа Ресерч Инститьют Оф Кемикал Текнолоджи Ингибиторы обратной транскриптазы вич
WO2010131118A2 (en) * 2009-05-12 2010-11-18 Pliva Hrvatska D.O.O. Polymorphs of etravirine and processes for preparation thereof

Also Published As

Publication number Publication date
RU2011129982A (ru) 2013-01-27
IL214862A (en) 2015-07-30
AP2011005715A0 (en) 2011-06-30
ES2527103T3 (es) 2015-01-20
WO2010150279A2 (en) 2010-12-29
IL214862A0 (en) 2011-11-30
UA106972C2 (uk) 2014-11-10
ZA201108690B (en) 2013-01-30
WO2010150279A3 (en) 2011-02-24
EP2342186A2 (en) 2011-07-13
EP2342186B1 (en) 2014-09-17
US20110196156A1 (en) 2011-08-11
JP2012509314A (ja) 2012-04-19
EP2342186A4 (en) 2012-03-21
JP5406934B2 (ja) 2014-02-05
BRPI1004934A2 (pt) 2016-11-29
RU2556986C2 (ru) 2015-07-20
CO6430461A2 (es) 2012-04-30

Similar Documents

Publication Publication Date Title
AP2858A (en) Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
HUS1900022I1 (hu) Gyógyszerészeti kompozíció, amely tartalmaz nem nukleozid reverz transzkriptáz inhibitort
BRPI1010624A2 (pt) método para a fabricação de gás de síntese
BRPI1013822A2 (pt) Método para síntese de um trissacarídeo.
SI2510089T1 (sl) Sinteza prazolnih spojin
ZA201102510B (en) Slurry process for synthesis of biophosphites
IL220106A (en) A method of producing a waterproof gypsum product
EG26900A (en) A process for synthesis of methanol
FI20095672A (fi) Menetelmä kalsiumkarbonaatin valmistamiseksi
IL214437A0 (en) Process for the synthesis of cleistanthin
EP2668176A4 (en) NEW PROCESS FOR SYNTHESIS OF POLYPHENOLES
HK1172844A1 (en) Synthesis of a neurostimulative piperazine
EP2507219A4 (en) SYNTHESIS OF SYRBACTINE PROTEASOMMER
PL2404400T3 (pl) Obsługa procesu związanego z modelem pokrycia w oparciu o maszynę stanu
EP2514719A4 (en) PROCESS FOR SYNTHESIS OF AMMONIA
ZA201200348B (en) A process for the synthesis of naratriptan
ZA201107258B (en) Autocatalytic process for the synthesis of chiral proparglic alcohols
ZA201203235B (en) Method fopr increasing the solubility of a transcriptase inhibitor composition
EP2900240A4 (en) CRYSTALLINE FORM OF REVERSE TRANSCRIPTASE INHIBITOR
SI2504309T1 (sl) Sinteza acetokslacetaldehida
TH116170B (th) กระบวนการใหม่สำหรับการสังเคราะห์อะโกเมลาทีน
PL389114A1 (pl) Sposób syntezy prekursorów samoprzylepnego kleju strukturalnego na bazie poliakrylanów
EP2773368A4 (en) COLLAGEN SYNTHESIS INHIBITION